We intend to focus our search on companies operating in the technology, media, telecommunications (“TMT”) and FinTech sectors that are headquartered in Europe, Israel, the Middle East or North America. Makram Azar, our CEO, has over 30 years of investment banking and private equity experience. He is the CEO and a director of Full Circle […]

We are a leading independent distributor and manufacturer of controlled environment agriculture (“CEA”, principally hydroWordPress 5.6ponics) equipment and supplies, including a broad portfolio of our own innovative portfolio of proprietary branded products. We primarily serve the United States and Canadian markets, and believe we are one of the leading competitors by market share in these […]

We intend to focus on opportunities aiming to make a positive social impact with a specific emphasis on good Environmental, Social and Governance (“ESG”) practices. (Note: Seven Oaks Acquisition upsized its IPO to price 22.5 million units, up from 20 million in the prospectus, at $10 each to raise $225 million.)

  While our efforts to identify a target business may span many industries and regions around the world, we intend to focus our search for prospects within the technology industry. We have not selected any potential business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or […]

While we will not be limited to a particular industry or geographic region, given the experience of our management team, our acquisition and value creation strategy will be to identify, acquire, and build a Silicon Valley-based technology company with applications in the energy or industrial sectors. Thurman J. “T.J.” Rodgers is our CEO, chairman and […]

PubMatic fuels the endless potential of Internet content creators. Our company provides a specialized cloud infrastructure platform that enables ad buyers to do real-time programmatic advertising transactions with publishers.  PubMatic was founded 14 years ago with the vision that data-driven decisions would be the future of advertising. We do not own media and we do not […]

We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Our mission is to expand the reach of targeted therapeutics by developing products for underserved populations. We utilize our deep expertise in structure-based drug discovery, translational research and patient-driven precision medicine, which we collectively […]

C3.ai is an Enterprise AI software company. We provide software-as-a-service, or SaaS, applications that enable the rapid deployment of enterprise-scale AI applications of extraordinary scale and complexity that offer significant social and economic benefit. All C3.ai software applications can be deployed on Azure, Amazon Web Services, or AWS, the IBM Cloud, Google Cloud Platform, or on-premise. […]

We are a clinical-stage biotechnology company pioneering a new class of therapeutics and seeking to develop functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. We have developed our Shielded Living Therapeutics, or SLTx, platform, which combines advanced cell engineering with cutting-edge innovations in biocompatible materials […]

We aim to enable exceptional scientific outcomes by commercializing transformative products for researchers to unlock deep, unbiased biological information. Our initial product, the Proteograph Product Suite (Proteograph), will leverage our proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome.  Proteins are the functional units of all forms of […]